{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:23:22Z","timestamp":1787829802933,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Department of Science & Technology (DST) WOS-A","award":["SR\/WOS-A\/LS-161\/2018 (G)"],"award-info":[{"award-number":["SR\/WOS-A\/LS-161\/2018 (G)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12655-4","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:11:05Z","timestamp":1787829065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PARP1 genetic variants modulate gene expression and cervical cancer susceptibility in a North Indian case-control study"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2907-1152","authenticated-orcid":false,"given":"Shireen","family":"Masood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7469-551X","authenticated-orcid":false,"given":"Jyotika","family":"Rajawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirti","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5371-8791","authenticated-orcid":false,"given":"Monisha","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"12655_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ijgo.70276","volume":"171","author":"S Wilailak","year":"2025","unstructured":"Wilailak S, Kengsakul M, Kehoe S (2025) Strategic approaches for global cervical cancer elimination: An update review and call for national action. Intl J Gynecol Obstet 171:120\u2013128. https:\/\/doi.org\/10.1002\/ijgo.70276","journal-title":"Intl J Gynecol Obstet"},{"key":"12655_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","volume":"40","author":"KS Okunade","year":"2020","unstructured":"Okunade KS (2020) Human papillomavirus and cervical cancer. J Obstet Gynaecol 40:602\u2013608. https:\/\/doi.org\/10.1080\/01443615.2019.1634030","journal-title":"J Obstet Gynaecol"},{"key":"12655_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Tao L, Qiu J et al (2024) Tumor biomarkers for diagnosis, prognosis and targeted therapy. Sig Transduct Target Ther 9:132. https:\/\/doi.org\/10.1038\/s41392-024-01823-2","journal-title":"Sig Transduct Target Ther"},{"key":"12655_CR4","doi-asserted-by":"publisher","first-page":"150943","DOI":"10.1016\/j.bbrc.2024.150943","volume":"738","author":"J Rajawat","year":"2024","unstructured":"Rajawat J, Banerjee M (2024) Poly(ADP-ribose) polymerase1 (PARP1) and PARP inhibitors: New frontiers in cervical cancer. Biochem Biophys Res Commun 738:150943. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150943","journal-title":"Biochem Biophys Res Commun"},{"key":"12655_CR5","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/med.21442","volume":"37","author":"J Rajawat","year":"2017","unstructured":"Rajawat J, Shukla N, Mishra DP (2017) Therapeutic Targeting of Poly(ADP-Ribose) Polymerase\u20101 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities. Med Res Rev 37:1461\u20131491. https:\/\/doi.org\/10.1002\/med.21442","journal-title":"Med Res Rev"},{"key":"12655_CR6","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1158\/2159-8290.CD-12-0120","volume":"2","author":"MJ Schiewer","year":"2012","unstructured":"Schiewer MJ, Goodwin JF, Han S et al (2012) Dual Roles of PARP-1 Promote Cancer Growth and Progression. Cancer Discov 2:1134\u20131149. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0120","journal-title":"Cancer Discov"},{"key":"12655_CR7","doi-asserted-by":"publisher","first-page":"e87057","DOI":"10.1371\/journal.pone.0087057","volume":"9","author":"R-X Hua","year":"2014","unstructured":"Hua R-X, Li H-P, Liang Y-B et al (2014) Association between the PARP1 Val762Ala polymorphism and cancer risk: evidence from 43 studies. PLoS ONE 9:e87057. https:\/\/doi.org\/10.1371\/journal.pone.0087057","journal-title":"PLoS ONE"},{"key":"12655_CR8","doi-asserted-by":"publisher","first-page":"e98022","DOI":"10.1371\/journal.pone.0098022","volume":"9","author":"Q Qin","year":"2014","unstructured":"Qin Q, Lu J, Zhu H et al (2014) PARP-1 Val762Ala polymorphism and risk of cancer: a meta-analysis based on 39 case-control studies. PLoS ONE 9:e98022. https:\/\/doi.org\/10.1371\/journal.pone.0098022","journal-title":"PLoS ONE"},{"key":"12655_CR9","doi-asserted-by":"publisher","first-page":"14639","DOI":"10.1111\/jcmm.16027","volume":"24","author":"H Li","year":"2020","unstructured":"Li H, Zha Y, Du F et al (2020) Contributions of PARP-1 rs1136410 C\u2009>\u2009T polymorphism to the development of cancer. J Cell Mol Med 24:14639\u201314644. https:\/\/doi.org\/10.1111\/jcmm.16027","journal-title":"J Cell Mol Med"},{"key":"12655_CR10","first-page":"7059","volume":"8","author":"L Zhai","year":"2015","unstructured":"Zhai L, Li S, Li H et al (2015) Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3\u2019 untranslated region and their association with PARP1 expression in breast cancer patients. Int J Clin Exp Pathol 8:7059\u20137071","journal-title":"Int J Clin Exp Pathol"},{"key":"12655_CR11","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s12035-015-9168-4","volume":"53","author":"H Wang","year":"2016","unstructured":"Wang H, Zhang K, Qin H et al (2016) Association Between PARP1 Single Nucleotide Polymorphism and Brain Tumors. Mol Neurobiol 53:2083\u20132089. https:\/\/doi.org\/10.1007\/s12035-015-9168-4","journal-title":"Mol Neurobiol"},{"key":"12655_CR12","doi-asserted-by":"publisher","first-page":"1610751","DOI":"10.3389\/pore.2022.1610751","volume":"28","author":"H Wang","year":"2022","unstructured":"Wang H, Xie H, Wang S et al (2022) PARP-1 genetic polymorphism associated with radiation sensitivity of non-small cell lung cancer. Pathol Oncol Res 28:1610751. https:\/\/doi.org\/10.3389\/pore.2022.1610751","journal-title":"Pathol Oncol Res"},{"key":"12655_CR13","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.31557\/APJCP.2020.21.10.2987","volume":"21","author":"R-M Zhou","year":"2020","unstructured":"Zhou R-M, Li Y, Wang N et al (2020) PARP1 Gene Polymorphisms and the Prognosis of Esophageal Cancer Patients from Cixian High-Incidence Region in Northern China. Asian Pac J Cancer Prev 21:2987\u20132992. https:\/\/doi.org\/10.31557\/APJCP.2020.21.10.2987","journal-title":"Asian Pac J Cancer Prev"},{"key":"12655_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bbrc.2006.12.162","volume":"354","author":"X-G Wang","year":"2007","unstructured":"Wang X-G, Wang Z-Q, Tong W-M, Shen Y (2007) PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochem Biophys Res Commun 354:122\u2013126. https:\/\/doi.org\/10.1016\/j.bbrc.2006.12.162","journal-title":"Biochem Biophys Res Commun"},{"key":"12655_CR15","doi-asserted-by":"publisher","first-page":"11061","DOI":"10.1007\/s11033-012-2009-x","volume":"39","author":"N Pabalan","year":"2012","unstructured":"Pabalan N, Francisco-Pabalan O, Jarjanazi H et al (2012) Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis. Mol Biol Rep 39:11061\u201311072. https:\/\/doi.org\/10.1007\/s11033-012-2009-x","journal-title":"Mol Biol Rep"},{"key":"12655_CR16","doi-asserted-by":"publisher","first-page":"300060521992956","DOI":"10.1177\/0300060521992956","volume":"49","author":"Y Xin","year":"2021","unstructured":"Xin Y, Yang L, Su M et al (2021) PARP1 rs1136410 Val762Ala contributes to an increased risk of overall cancer in the East Asian population: a meta-analysis. J Int Med Res 49:300060521992956. https:\/\/doi.org\/10.1177\/0300060521992956","journal-title":"J Int Med Res"},{"key":"12655_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2350-11-38","volume":"11","author":"XM Jin","year":"2010","unstructured":"Jin XM, Kim HN, Lee I-K et al (2010) PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males. BMC Med Genet 11:38. https:\/\/doi.org\/10.1186\/1471-2350-11-38","journal-title":"BMC Med Genet"},{"key":"12655_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.21037\/tcr.2016.09.01","volume":"5","author":"X-B Ma","year":"2016","unstructured":"Ma X-B, Wang X-J, Wang M et al (2016) Impact of the PARP1 rs1136410 and rs3219145 polymorphisms on susceptibility and clinicopathologic features of breast cancer in a Chinese population. Transl Cancer Res 5:520\u2013528. https:\/\/doi.org\/10.21037\/tcr.2016.09.01","journal-title":"Transl Cancer Res"},{"key":"12655_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.bjc.6605166","volume":"101","author":"T Zaremba","year":"2009","unstructured":"Zaremba T, Ketzer P, Cole M et al (2009) Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines. Br J Cancer 101:256\u2013262. https:\/\/doi.org\/10.1038\/sj.bjc.6605166","journal-title":"Br J Cancer"},{"key":"12655_CR20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/s41419-021-04229-y","volume":"12","author":"G Raspaglio","year":"2021","unstructured":"Raspaglio G, Buttarelli M, Filippetti F et al (2021) Stat1 confers sensitivity to radiation in cervical cancer cells by controlling Parp1 levels: a new perspective for Parp1 inhibition. Cell Death Dis 12:933. https:\/\/doi.org\/10.1038\/s41419-021-04229-y","journal-title":"Cell Death Dis"},{"key":"12655_CR21","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2967\/jnumed.120.253575","volume":"62","author":"PD de Souza Fran\u00e7a","year":"2021","unstructured":"de Souza Fran\u00e7a PD, Guru N, Kostolansky AR et al (2021) PARP1: A Potential Molecular Marker to Identify Cancer During Colposcopy Procedures. J Nucl Med 62:941\u2013948. https:\/\/doi.org\/10.2967\/jnumed.120.253575","journal-title":"J Nucl Med"},{"key":"12655_CR22","doi-asserted-by":"publisher","first-page":"e37446","DOI":"10.1371\/journal.pone.0037446","volume":"7","author":"F Ye","year":"2012","unstructured":"Ye F, Cheng Q, Hu Y et al (2012) PARP-1 Val762Ala Polymorphism Is Associated with Risk of Cervical Carcinoma. PLoS ONE 7:e37446. https:\/\/doi.org\/10.1371\/journal.pone.0037446","journal-title":"PLoS ONE"},{"key":"12655_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s40291-013-0036-5","volume":"17","author":"A Roszak","year":"2013","unstructured":"Roszak A, Lianeri M, Sowi\u0144ska A, Jagodzi\u0144ski PP (2013) Involvement of PARP-1 Val762Ala Polymorphism in the Onset of Cervical Cancer in Caucasian Women. Mol Diagn Ther 17:239\u2013245. https:\/\/doi.org\/10.1007\/s40291-013-0036-5","journal-title":"Mol Diagn Ther"},{"key":"12655_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s43168-026-00519-1","volume":"20","author":"O Masood","year":"2026","unstructured":"Masood O, Devi A, S, et al (2026) Association of the CCL2 A\/G (rs3760399) gene variant and its expression with COPD risk and response to combined budesonide\/formoterol therapy. Egypt J Bronchol 20:12. https:\/\/doi.org\/10.1186\/s43168-026-00519-1","journal-title":"Egypt J Bronchol"},{"issue":"05","key":"12655_CR25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1055\/s-0037-16130892002;87","volume":"87","author":"EM Bladbjerg","year":"2002","unstructured":"Bladbjerg EM, Gram J, Jespersen J, de Maat MP (2002) Internal quality control of PCR-based genotyping methods in research studies and patient diagnostics. Thromb Haemost 87(05):812\u2013816. https:\/\/doi.org\/10.1055\/s-0037-16130892002;87","journal-title":"Thromb Haemost"},{"key":"12655_CR26","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.genrep.2025.102344","volume":"41","author":"S Masood","year":"2025","unstructured":"Masood S, Kushwah AS, Srivastava K, Banerjee M (2025) Association of CDH1 gene variant C\u2009>\u2009A (rs16260) with expression and treatment outcomes in cervical cancer patients receiving chemoradiotherapy. Gene Rep 41:102344. https:\/\/doi.org\/10.1016\/j.genrep.2025.102344","journal-title":"Gene Rep"},{"key":"12655_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/CEJ.0000000000000708","volume":"31","author":"K Anjali","year":"2022","unstructured":"Anjali K, Singh D, Kumar P et al (2022) PARP1 rs1136410 (A\/G) polymorphism is associated with early age of onset of gallbladder cancer. Eur J Cancer Prev 31:311\u2013317. https:\/\/doi.org\/10.1097\/CEJ.0000000000000708","journal-title":"Eur J Cancer Prev"},{"key":"12655_CR28","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1080\/01443615.2022.2114325","volume":"42","author":"J Zhao","year":"2022","unstructured":"Zhao J, Zhao T (2022) A functional polymorphism in the poly(ADP-ribose) polymerase-1 gene increases the risk of endometrial carcinoma. J Obstet Gynaecol 42:3299\u20133303. https:\/\/doi.org\/10.1080\/01443615.2022.2114325","journal-title":"J Obstet Gynaecol"},{"key":"12655_CR29","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1111\/jcmm.15058","volume":"24","author":"M Avitabile","year":"2020","unstructured":"Avitabile M, Lasorsa VA, Cantalupo S et al (2020) Association of PARP1 polymorphisms with response to chemotherapy in patients with high-risk neuroblastoma. J Cell Mol Med 24:4072\u20134081. https:\/\/doi.org\/10.1111\/jcmm.15058","journal-title":"J Cell Mol Med"},{"key":"12655_CR30","doi-asserted-by":"publisher","unstructured":"Eedarapalli P, Dwivedi R, Kar A (2021) Smoking, Cervical Precancer and Cancer. Indian J Gynecol Oncolog 19. https:\/\/doi.org\/10.1007\/s40944-021-00528-6","DOI":"10.1007\/s40944-021-00528-6"},{"key":"12655_CR31","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ijgo.70276","volume":"171","author":"S Wilailak","year":"2025","unstructured":"Wilailak S, Kengsakul M, Kehoe S (2025) Strategic approaches for global cervical cancer elimination: An update review and call for national action. Int J Gynecol Obstet 171:120\u2013128. https:\/\/doi.org\/10.1002\/ijgo.70276","journal-title":"Int J Gynecol Obstet"},{"key":"12655_CR32","doi-asserted-by":"publisher","first-page":"e41477","DOI":"10.7759\/cureus.41477","volume":"15","author":"J Zreik","year":"2023","unstructured":"Zreik J, Takagi MA, Akhter MF et al (2023) Sociodemographic disparities in the diagnosis and prognosis of patients with cervical cancer: an analysis of the surveillance, epidemiology, and end results program. Cureus 15:e41477. https:\/\/doi.org\/10.7759\/cureus.41477","journal-title":"Cureus"},{"key":"12655_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12905-025-03841-w","volume":"25","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Fan Z, Wang J et al (2025) HPV vaccination, screening disparities, and the shifting landscape of cervical cancer burden: a global analysis of trends, inequalities, and policy implications. BMC Womens Health 25:285. https:\/\/doi.org\/10.1186\/s12905-025-03841-w","journal-title":"BMC Womens Health"},{"key":"12655_CR34","doi-asserted-by":"publisher","first-page":"1400667","DOI":"10.3389\/fphar.2024.1400667","volume":"15","author":"C Guo","year":"2025","unstructured":"Guo C, Zhan B, Li MY et al (2025) Association between oral contraceptives and cervical cancer: A retrospective case\u2013control study based on the National Health and Nutrition Examination Survey. Front Pharmacol 15:1400667. https:\/\/doi.org\/10.3389\/fphar.2024.1400667","journal-title":"Front Pharmacol"},{"key":"12655_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.gene.2016.11.019","volume":"600","author":"N Cui","year":"2017","unstructured":"Cui N, Qiao C, Chang X, Wei L (2017) Associations of PARP-1 variant rs1136410 with PARP activities, oxidative DNA damage, and the risk of age-related cataract in a Chinese Han population: A two-stage case-control analysis. Gene 600:70\u201376. https:\/\/doi.org\/10.1016\/j.gene.2016.11.019","journal-title":"Gene"},{"key":"12655_CR36","doi-asserted-by":"publisher","first-page":"101825","DOI":"10.1016\/j.cegh.2024.101825","volume":"30","author":"S Masood","year":"2024","unstructured":"Masood S, Kushwah AS, Yadav A et al (2024) A study on socio-demographic-based knowledge and awareness for cervical cancer among women from Uttar Pradesh, India. Clin Epidemiol Global Health 30:101825. https:\/\/doi.org\/10.1016\/j.cegh.2024.101825","journal-title":"Clin Epidemiol Global Health"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12655-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:11:06Z","timestamp":1787829066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12655-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12655"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12655-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"26 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were done in accordance with laws, institutional norms and authorized by Ethics Committee at the King George Medical University, Lucknow (256\/Ethics\/R.Cell-18 dated by 24.09.2018).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1470"}}